Our Firm is already representing a number of Stryker hip recall clients in this litigation, and we are very pleased with the pace of its progress.
New York, New York (PRWEB) October 02, 2013
Hundreds of Stryker hip lawsuit (http://www.strykerhiprecall.net/) claims filed in New Jersey’s Bergen County Superior Court in the wake of last year’s Stryker hip recall for Rejuvenate and ABG II Modular-Neck Hip Stems continue to move forward, Bernstein Liebhard LLP reports. According to a Case Management Order issued on September 24th, the parties are to select two Stryker hip lawsuits by October 15th for the first phase of the litigation’s early mediation efforts. A mediation session will begin no later than December 15th. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“Our Firm is already representing a number of Stryker hip recall clients in this litigation, and we are very pleased with the pace of its progress,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free Stryker hip lawsuit evaluations to individuals who have suffered serious complications, allegedly due to the Rejuvenate and ABG II hip stems.
Stryker Hip Recall
Court records indicate that more than 380 Stryker hip lawsuits have been filed in the multicounty litigation underway in New Jersey. All of the claims pending in the proceeding allege that the Rejuvenate and ABG II components can release toxic metal ions when they fret and corrode at the modular-neck junction. Plaintiffs further allege that they have developed metallosis, necrosis, osteolysis, and other complications that result in failure of the hip, due to the accumulation of this metallic debris in the surrounding tissue and blood stream. The next Case Management Conference in the New Jersey Stryker hip recall litigation has been scheduled for October 23, 2013.
According to court documents, at least 290 additional Stryker hip lawsuits involving similar allegations are pending in a federal multidistrict litigation underway in U.S. District Court, District of Minnesota. That proceeding’s next Status Conference is scheduled for November 21, 2013. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
Stryker Rejuvenate and ABG II hip stems were subject to a global recall in July 2012, after it became apparent that the metal hip stems were subject to a high rate of fretting and corrosion at the modular neck junction. Stryker has advised all Rejuvenate and ABG II recipients to undergo blood testing and cross sectional imaging, even if they were not experiencing any pain, swelling, or other symptoms that would indicate the devices are failing. According to the company, some Stryker hip recall patients have developed adverse local tissue reactions, even though they weren’t experiencing any problems with their hips.
Recipients of Rejuvenate and ABG II hip stems may be eligible to file a Stryker hip lawsuit seeking compensation for medical bills, lost wages, and pain and suffering if they developed complications allegedly related to the Stryker recall. Click Here to learn how to contact a Stryker hip lawyer at Bernstein Liebhard LLP for a free case evaluation. For more information, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP